❭ Research by medical division ❭ Cancer Medicine ❭ Department of Oncology ❭ Cellular therapy ❭ News

Two new publications with group members

A vaccine study with Ultimovacs involving Else Marit Inderberg :

A study with our friends from Cancer Immunology (Smeland/Myklebust team) involving Sébastien Wälchli:

 

 
Scroll to top

Home Department of Oncology Cellular therapy

  • Units
    • Advanced Cell Therapy Unit – ACT Centre
    • Cell Therapy Laboratory Unit
    • Quality Unit
    • Translational research unit (TRU)
    • Islet Cell Group [Scholz]
  • Group members
  • Publications
  • Vacant positions
  • External collaborators
  • News
  • Links

Recent publications

Mensali N, Joaquina S, de Montlaur C, Casey NP, Nesset TO, Myklebost O, McCormack E, Pasetto A, Gunnes MW, Gelebart P, Inderberg EM, Wälchli S (2026)
Pre-clinical validation of OSCAR-3 mRNA-based CAR T cells for targeting osteosarcomas
Cytotherapy, 28 (12), 102930
DOI 10.1016/j.jcyt.2026.102930, PubMed 42854615

Forcados C, Köksal H, Scherer E, Abrantes R, Dillard P, Duarte HO, Josefsson S, Gomes C, de Montlaur C, Hellesøy HTZ, Dunkel R, Smeland EB, Myklebust JH, Reis CA, McCormack E, Gelebart P, Inderberg EM, Wälchli S (2026)
Reviving low-affinity glycan-targeting CAR with combinatorial design
Cell Rep Med, 7 (10), 103108
DOI 10.1016/j.xcrm.2026.103108, PubMed 42849448

Villatoro A, Dougé A, Krpina K, Schmitz LM, Forcados C, Kaveh F, Arias-Díaz AE, Gelebart P, McCormack E, Stripecke R, Abal M, Davidson B, Inderberg EM, Wälchli S (2026)
Combining TAG-72CAR with anti-MUC16CAR improves the potency of ovarian cancer treatment
FEBS J (in press)
DOI 10.1111/febs.70760, PubMed 42834815

More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)